Introduction
The use of novel illicit drugs and the constant appearance of new psychoactive substances have rapidlyg rown in the last years, and reports of the availability and manufacture of such substances have increased. [1] Illicit drugs are those for which nonmedicalu se has been prohibited by internationalc ontrol treaties because theya re believed to presentu nacceptable risks of addiction to users. According to the FDA, these compounds can also be defined as "drugso fa buse", substances that are used in am anner or amount inconsistentw ith the legitimate medicalu se. [2] The problematic use of these illicit drugs is associated with considerable mortality and morbidity. During the last 30 years, international control has been extended from plant-based drugs (e.g. heroin, cocaine, and cannabis) to synthetic drugs (e.g. amphetamines,3 ,4-methylenedioxymethamphetamine, etc.) and pharmaceutical drugs (e.g. buprenorphine, methadone, benzodiazepines, etc.). Specifically,s ynthetic drugs are proliferating at an unprecedented rate and are posing significant public health challenges. The majority of these addictive substances, directly or indirectly,a ttack the brain's rewards ystem, mainly serotonin and dopamine receptors, which regulate movement,e motion, motivation, and, above all, the feelings of pleasure and euphoria associated with the consumption of narcotics. Nowadays, amidst all illicit/ abuse substances,c annabis is the most consumed drug worldwide with 183 millione uro incautions, followed by amphetamines and derivatives (37 million euro), opioids (35 million euro), ecstasy( 22 million euro), opiates (18 millione uro), and cocaine(17 million euro). According to their pharmacologic behavior,d rugs can be divided into depressants, stimulants, hallucinogenic, and opioids.
Because of their harmfulnesst oh ealth,t he ability to detect and quantify "drugso fa buse" in af ast, easy,a nd reliable way is crucial. The United Nations Office on Drugs and Crime (UNODC)e stablished 28 million years of healthyl ife lost worldwide in 2015 because of premature death and disability caused by drug use. [3] Apart from the health problemsgenerated by illicit drug consumption, UNODC exposes the existence of continue evolvingo rganized crime/terrorism related with drug market. The European homologue,E uropean Monitoring Centref or Drugs and Drug Addiction (EMCDDA), assumes there exists an important internet market dedicated to the sale of illicit substancesp rotected by anonymization services. [4] Last annualinforms of both the UNODCSa nd EMCDDAemphasized the necessity to control the production and distribution of new psychoactive substances( NPSs), as there are no assurances to the consumers of the compounds contained,a nd the need to reinforce the development of new detection systems with the aim to decrease and eliminate the abuse of traditional and synthetic emerging drugs. [5] The development of reliable methodsfor their detection and quantification is timely and urgently required.
Nowadays, illicit drug detection is performed mostly through chromatographic techniques, as can be seen by the large number of research articles published in this field, because of the excellent features of chromatographict echniques, which include great versatility,r obustness, and sensibility.
[6] Several electrochemical, [7] infrared, [8] Raman spectroscopy, [9] and magnetic resonance [1] methods also exist for the detection of several drugs, and these techniques show excellent results in terms of selectivity and sensibility.However,they presentsome shortcomings such as high cost, the use of trained personnel, tedious sample pretreatment, and so on. As an alternative to these traditional techniques, the design of molecular probesf or the undemandingc hromo-and fluorogenic detection of illicit drugs can be of importance.B oth chromogenic and fluorogenic probes provides everal advantages over other traditional analytical techniques, such as their chemical simplicity,e ase of use, rapid response suitable forr eal-time on-sited etection, easy detection to the naked eye, and so on. [10] Despite these remarkable features, the development of chromo-and fluorogenic sensors for the selective ands ensitive detection of certain illicit drugsi ss till poorly explored. In this review,athorough overview of chromogenica nd fluorogenic sensing systems for the detection of most consumed drugs is provided.
The consumption of illicit drugs has increased exponentially in recent years and has become ap roblem that worries both governments and international institutions. The rapid emergence of new compounds, their easy access,t he low levels at which these substances are able to produce an effect, and their short time of permanence in the organism makei tn ecessary to develop highly rapid, easy,s ensitive,a nd selective methods for their detection. Currently,t he most widely used methods for drug detection are based on techniques that require large measurement times, the use of sophisticated equipment, and qualified personnel. Chromo-a nd fluorogenic methods are an alternative to those classical procedures. -- [14] GHB colorimetric sensor water -GBL, 1,4-butanediol, propionic acid, butyric acid, and common salts [15] GHB iridium(III) chemosensor water,black tea, soda, orangejuice, red wine, whisky, and milk 0.15 - [16] CPH spectrophotometric methodwater and pharmaceutical formulations 1.7 10
À3
- [17] ketamine hydrochloride colorimetric test water and pharmaceutical formulations 5- [18] ketamine colorimetric test water 100 AMP,M AMP,M DMA, cocaine,E PH, scopolamine, caffeine, acetaminophen,i buprofen, acetylsalicylic acid, starch, sugars, and MgSO 4 [20, 21] drugs containingc yclic a-methylene carbonyl groups fluorometricm ethodpharmaceutical preparations and biofluids 3 10 À9 to 2 10
À5
- [22] dextromethorphans pectrophotometric methodpharmaceuticals preparations 3.5 10
À3
- [23] morphine and codeineAuNPs human serum, urine samples, and pharmaceutical formulations 4.85 10 À6 and 2. 69 10 À6 cations, anions, ascorbicacid, glucose, urea, cysteine, glutamic acid, asparagine,l eucine, valine,proline, phenylalanine, tramadol,AMP, and MAMP [24] STIMULANTD RUGS - [38] MDMA and MDA colorimetric reaction sulfuric acid aqueous (75 %, w/v) 0.19 - [39, 40] MA NPs toluene and vaporo-toluidine, hexylamine, diethylamine,dibutylamine, allylamine, trimethylamine, and aniline [41] catecholaminemolecularr ecognition water-biogenica mines, sugars, neurotransmitters, and aminoa cids [42] phenothiazinedrugs spectrophotometric methodsulfuric acid -- [43] ChemistryOpen 2018, 7,401 -428
MA, EPH,a nd
www.chemistryopen.org 2018 The Authors. Publishedb yWiley-VCH Verlag GmbH &Co. KGaA, Weinheim [50] cocaineaptamern anomachine (FRET processa llowed or not depending on the analyte) water 1.5 10
À4
- [51] cocaineaptamern anomachine and amplified aptamer nanomachine (quenching off/on process) water 3.0 10 À5 for normal and 3.5 10 À17 for amplified process - [52] cocaineaptamern anomachine (quenching off/on process)
water,saliva, serum, and urine
10

À6
- [53] cocaineaptasensorcombined with CQDs (quenching off/on process) water 6.1 10
À7
benzoylecgonine and ecgonine methyl ester [54] cocaineaptasensorcombined with CQDs (quenching off/on process) morphine and heroine [59, 61] cocaineaptasensor(quenching off/on process) buffered solution 3.0 10
À5
benzoylecgonine and ecgonine methyl ester [62] cocaineaptasensor(quenching off/on process) serum 3.0 10
À4
benzoylecgonine and ecgonine methyl ester [63] cocaineaptasensor(molecular displacement of dye and increase in absorptionb and) buffered solution 6.1 10
À5
benzoylecgonine and ecgonine methyl ester [64] cocaineaptasensor(conformation changes after molecular recognition of analyte, highfluorescence anisotropy) buffered solution 1.5 10
À4
theophylline, caffeine,B SA, IgG,a rginine, phenylalanine, and aspartic acid [65] cocaineaptasensor(conformation changes after addition of analyte in presence of CuNPs) water 3.0 10 À3 ecgonine, pethidine, and methadone [66] cocaineaptasensorcombined with GO and AuNPs (quenching off/on process) plasma and serum 3.0 10
À3
pethidine and methadone [67, 68] cocaineaptasensorcombined with AuNPs (changesi nabsorption band due to aggregation of AuNPs) [88] [a] LOD:l imit of detection;G BL: g-butyrolactone;GHB: g-hydroxybutyric acid;C PH:c hlorpromazine hydrochloride;A MP:amphetamine; MA:m ethamphetamine; MDMA: 3,4-methylenedioxymetamphetamine; MDA:3 ,4-methylenedioxyamphetamine;E PH:e phedrine;M eEPH:m ethylephedrine;T HC:t etrahydrocannabinol;P EPH:p seudoephedrine;D OM:2 ,5-dimethoxy-4-methylamphetamine;A MPH:( + +)-amphetamine sulfate;M ETH: (+ +)-methamphetamine hydrochloride;D A: dopamine;P EA:2 -phenylethylamine;E DDP:2 -ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine; mCPP: meta-chlorophenylpiperazine;I gG: immunoglobulin G; BSA:bovine serum albumin. 
Depressant Drugs
Depressant drugs slow down the nervous system and brain activity and thus have as edating effect. [11] Most depressants affect one of the brain's neurotransmitters, that is, g-aminobutyric acid (GABA), which upon activation produces as ense of calm and relaxation. GABA is the chief inhibitory neurotransmitter in the mammalian centraln ervous system (CNS), and its principal role is to reduce neuronal excitability.D epressant drugs have the particularity that often leads to "drug tolerance", which makes the organism ask for higher doses until dependence or overdosea rises. Coma, respiratory diseases,a nd death are the potentialc onsequences of their continuous consumption.D epressant drugs comprise barbiturates, benzodiazepines, alcohol, and g-hydroxybutyrate.
In 2013, Chang and co-workers reported boron-dipyrromethene (BODIPY)f luorescents ensor 3 for g-butyrolactone (GBL) detection in water and in different alcoholicd rinks ( Figure 1) . [12] GBL is ap rodrug of g-hydroxybutyric acid (GHB), and its relevance is due to the strong regulation to which GBH is subject, but this is not applicable to GBL. GBL overdose causes irrational behavior,s evere sickness, coma, and death. [13] Sensor 3 shows am arked absorption band centered at l = 569 nm in water.B esides,u pon excitation at l = 569 nm, a small emission band at l = 582 nm (with al ow quantum yield of 0.05) is observed. The addition of GBL to an aqueous solution of 3 induces an emissione nhancement at l = 582 nm ( % 10-fold). Al imit of detection for GBL by using 3 is reported to be 3mgmL
À1
.T he off-on emission response is related with the hydrophobic character of the probe.T he authors indicate that probe 3 forms nonemissive aggregates in water that are progressively broken upon coordination with GBL with as ubsequent enhancement in emission. In addition, probe 3 can be used to detect GBL in drink samples after as imple extraction process.T he presence of GBLi ss imply assessed by irradiation with ag reen laser pointer;t his induces the appearance of orange fluorescence, whichi sn ot observed in samples without the drug.
The same authors also report on the preparation of BODIPY probe 4 (Figure 1 ) for the fluorogenic detection of GHB. [14] Ethanol/water (1:1, v/v)s olutions of 4 show an absorption band at l = 557 nm and emission at l = 574 nm. The addition of GHB induces moderate emission quenching (2.2-fold in the presence of 10 mg mL À1 of the drug)o ft he band at l = 574 nm. This behavior can be ascribed to the formation of ah ydrogen bond between the phenolic hydrogen atom of the probe and the carboxylate moiety of the drug. As ac onsequence of the coordination,aphotoinduced electron-transfer (PET) process is activated, which induces the observed emission quenching. Moreover,t he authors demonstrate that probe 4 can be used to detectG HB easily in severalb everages (alcoholics, nonalcoholics, colored, and colorless). For this purpose, 4 is dissolved in DMSO and then mixed with the beverages spiked with known amounts of GHB (1:1, v/v,f inal solution). Irradiation of the prepared samples with ah and-held lamp (l = 365 nm) allows differences in the fluorescence intensities of GHB-free and GHB-spiked beverages to be observed clearly by the naked eye.
Garcia andc o-workers have developed ac olorimetric sensor array for the detection of GHB. [15] The array is composed of three columns and six rows. The first column has six tricyclic dyes (methylene blue, thionine, oxonine, pyronine, acridine orange, and proflavine), the second column is formed by the same dyes complexed with cucurbit [7] ril (CB [7] ), and the third columnc ontains the dyes complexed with cucurbit [8] ril (CB [8] ). The addition of GBH (in the 0.1-10 À5 m range) to the sensor array inducesr emarkable color changes in some plates due to the dethreading of CB [7] and CB [8] complexes with the dyes after coordination of the macrocycles with the drug. The colors obtained are ascribed to the different stabilityc onstants for the dye-CB complexes and tot he ability of GBH to disrupt the formed supramolecular ensembles. Moreover, the chromogenic response of the array to GHB is quite selective, and other possible interferents, such as GBL, 1,4-butanediol, propionic acid, butyric acid, and common salts present in water, are unable to induce color changes.
Ma and co-workerso utline the synthesis of al ong-lived iridium(III)c hemosensor,t he luminescence emission of whicha t l = 570 nm is quenchedi nt he presence of GHB (Figure 2 ). [16] Due to its long-lived luminescence, time-resolved emission spectroscopy (TRES) allows the detection of GBH. Aq uenching effect of 30 %l uminescence emission is observed 10 sa fter the addition of al ow concentration of GBH (0.15 mg mL À1 )t oasolution of the complex. This quenching is clearly seen by the naked eye under UV illumination and is not pH dependent. Real samples of water,b lack tea, soda, orange juice, red wine, whisky,a nd milk previously spiked with GHB have been evaluated, which assurest he suitabilityo ft his procedure for GHB drug detection over awide range of real-lifebeverages.
Al-Kaffiji and co-workers have developed as pectrophotometric methodf or the opticald etection of chlorpromazine hydrochloride( CPH). CPH pertains to the family of drugs commonly known as neuroleptic tranquilizers (used as sedatives, antihistamines, and anesthetics) but nowadays is commonly mixed with narcotic drugs. [17] The method is based on the reaction of p-aminoacetanilide (7)w ith CPH in the presenceo fa n oxidizinga gent (i.e. ferric chloride hexahydrate). This reaction yields an intense violet product (see structure 8 in Scheme1) with an intense absorption band at l = 590 nm. Probe 7 has successfully been applied to the determination of CPH in aqueous solutionsa nd pharmaceutical formulations with high accuracy and shows al inear range between 4a nd 32 ppm with a limit of detection of about 1.7 ppm.
Morrish as developedacolorimetrict est for ketamine hydrochlorideo nt he basis of at ypical cocaine detectiona ssayb y using Co(SCN) 2 . [18] Ketamine is am edication mainly used for startinga nd maintaining anesthesia, but it is also ad rug for recreational purposes. Unregulated use has side effects such as high bloodp ressure, abnormal heart rhythms,v omiting, double and tunnelv ision, anaphylaxis, airway obstruction, and dependence. [19] The test consists of the basification of the samples (with sodiumh ydroxide) followed by the addition of Co(SCN) 2 .T his two-stepp rocedure results in the formation of a lavender to purple precipitate in the presence of ketamine, whereas ab lue to green precipitate is obtained in the absence of ketamine. Sensibility as high as 5mgmL À1 can be achieved, which is good enough for the detection of this drug in commercial productsf or medical applications( contents ranging from 50 to 100 mg mL À1 ). Selectivity studies show that other controlled substances and related chemicals yield an egative response.
Herrµez-Hernµndez and co-workers follow as imilar reaction for the colorimetric sensing of ketamine by immobilizing different amounts of the Co(SCN) 2 reagento nto ap olydimethylsiloxane (PDMS) matrix. [20] For the preparation of the materials, the authors disperse Co(SCN) 2 in an aqueous solutionc ontaining tetraethylorthosilicate (TEOS) ande xpose the resulting dispersion to PDMS to embed Co(SCN) 2 in the polymer matrix. [21] Once the sensing material is prepared, pure ketamine detection can be performed by immersing the sensori n0 .1 m NaOH solutionso ft he drug. In the presenceo fk etamine, ap urple precipitate on the surface of the matrix polymer is formed. However,a fter af ew minutes, this precipitated isappears, and the solid changes from brown to purple because of the diffusion of ketaminei nside the polymer and the formation of a complexb etween Co(SCN) 2 and the drug. The best response is observed for as olid containing 0.3 %C o(SCN) 2 at l = 625 nm. Al imit of detection of 100 mgmL À1 for ketaminei sr eported. Besides, no interference is observed if the sensing materiali s exposed to amphetamine, methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA), cocaine, ephedrine, scopolamine, caffeine, acetaminophen, ibuprofen, acetylsalicylic acid, starch, saccharose,g lucose, lactose, and magnesium sulfate. The material has been tested in real samples with fine results.
Elokely and co-workersd escribe the designo fanew fluorometricm ethodf or the detection of drugs containing cyclic amethylene carbonyl groups in pharmaceuticals, preparations, and biofluids by using N-methylnicotinamide chloride (NMNCl) as af luorogenic reagent (Scheme 2). [22] In basic media, N-methylnicotinamide chloride forms neutral and highly reactive acarbinol compound 12,w hich reacts with drugs containing cyclic a-methylene carbonyl groups (such as 9, 10,a nd 11)t o yield fluorescent derivative 15.T he test is quite sensitive with limits of detection in the 0.003-20 ng mL À1 range. The authors also demonstrate the possible use of N-methylnicotinamide for the detection of drugs 9, 10,a nd 11 in plasma samples with nearly the same limits of detection obtained upon using water.
Elmosallamya nd Amin have developed an ew spectrophotometric method for the detection of dextromethorphan (16) (Figure 3 ) in pharmaceutical preparations. [23] The spectrophotometric protocol involves the reaction between dextromethorphan hydrobromide with eriochrome black T( 17)i na cetate buffer (pH 2.8), which resultsi nt he formation of an ion-pair complex with an absorption band at l = 520 nm. This method for the detection of 16 is lineal in the 7.37-73.7 10 À5 m range with alimit of detection of 1. 29 10 À5 m. Mohseni and Bahram outline the use of melamine-coated gold nanoparticles (AuNPs) for the detection of morphine and codeine in human serum, urine samples, andp harmaceutical formulations. [24] The presence of melamine molecules in the Scheme1.Oxidation reaction with p-aminocetanilide (7)a nd ferric chloride for the detection of chlorpromazine drug 6.
Scheme2.Chemical structures of drugs 9-11 containingc yclic a-methylene carbonyl groups, and syntheticpathwayfor the preparationo ffluorophore 15. outer sphere of the AuNPs prevents aggregation,a nd aqueous solutionso ft he nanoparticles present as aw ine-red color (absorptionband centered at l = 675 nm). In the presenceo fmorphine and codeine, am arked color change to blue is observed (absorbance band at l = 690 nm) due to the aggregationo f the AuNPsi nduced by the formation of hydrogen bonds between melamine and the drugs. The proposed method exhibits lineal ranges of 0.07 to 3 mm for morphine and 0.03 to 0.8 mm for codeine with limits of detections of 17 and 9nm,r espectively.I nterference studies show that cations, anions, ascorbic acid, glucose,u rea, cysteine, glutamic acid, asparagine, leucine, valine, proline, phenylalanine, tramadol, amphetamine, and methamphetamine are unable to induce color modulations. Besides, melamine-coated AuNPs have also been used for the detection of morphine and codeine in biological fluids and pharmaceutical formulations with fine results. The probes described in this sectiona re based on different chemicalr eactions and the formation of complexes with depressant drugs.A lso, the analyte-induced aggregation of AuNPs hasb een used to detect morphine and codeine. High selectivity andl ow detection limits are achieved with mosto f the probese xposed above,a nd thus, they are good alternatives for traditional chromatographic methods. Naked-eye detection, short analysis times, and no need for overqualified personnelf or their daily use are some of the advantages of these sensing probes. Besides, some probes have been tested in real human body fluids,a nd thus, some of these reported examples could have potential applications for the development of realistic systems for the detection of depressant drugs.
Stimulant Drugs
Stimulant drugs accelerate the activity of the central nervous system.I fh igh doses are taken,e levated blood-pressure levels and increased heart and respiration rates may ensue, with the potentialr isk for cardiovascular failure;h owever,t hesed rugs can also make consumersf eel angry and/or paranoid. [25] Normally,t hese drugs inhibit the reuptakeo fs erotonin, norepinephrine, andd opamine, which resultsi ng reater concentrationso ft hese three neurotransmitters in the brain, and this leads to multiple effects on the state of mind of the individual user.T here are an umber of stimulant drugs,i ncluding those that are legal and prescribed by doctors and those that are considered illegal. In the group of legal drugs, caffeine and nicotine are the most common. On the other hand, cocaine, crack, amphetamine, and their derivatives are found among illegal stimulant drugs.
Sakai and Ohno describe ap rocedure for the sensitive and selective detection of methamphetamine, ephedrine, and methylephedrinei nu rine (Scheme3). [26, 27] The method consists in the extraction of basified urine containing the drugs with 1,2-dichloroethane. Then, the organic phase, whichc ontains the drugs, is added to a1 ,2-dichloroethane solution of tetrabromophenolphthalein ethyl ester (18) . After af ew minutes, colored product 19 is formed. The absorption maximaa re found at l = 570 nm for methamphetamine, l = 555 nm for ephedrine, and l = 550 nm for methylephedrine. The procedure described presentsh igh selectivity,a nd calcium chloride, sodium chloride, magnesium chloride, sodium nitrate, sodium acetate, Al ,ammonium ions, urea, uric acid, creatinine,a nd hippuric acid are all unable to induce any chromogenic response. In addition, the limits of detection are 3.75 mgmL À1 for methamphetamine, 4.13 mgmL À1 for ephedrine, and 4.48 mgmL À1 for methylephedrine. Herrµez-Hernµndez and co-workers embed 1,2-naphthoquinone-4-sulfonate 20 ( Figure 4 ) into polydimethylsiloxane/tetraethylorthosilicate/silicon dioxide nanoparticles and use this mixture to identify amphetamine (AMP), methamphetamine (MAMP), 3,4-methylenedioxymethamphetamine (MDMA), and 3,4-methylenedioxyamphetamine (MDA) chromogenically. [28] Basic buffered aqueous suspensions of the nanoparticles show al ight yellow color due to the presence of ab road absorption band at around l = 460 nm. Upon the addition of amphetamines, clear colorc hanges to orange (for MAMP and MDMA, which are secondary amines)o rg ray-brown (for AMP and MDA, which are primarya mines) are observed. Limits of detection in the 0.002-0.005 gmL À1 range are found. The prepared sensing materiald isplays better selectivity for amphetamines than for other drugs such as cocaine, cannabinol, cannabidiol, tetrahydrocannabinol( THC), scopolamine, ephedrine, and pro- caine. The only two drugs that interferewitha mphetamine detection are ephedrine and prococaine. The application of this sensing system to real ecstasy samples allows the percentage of amphetamine contained in the pills to be calculated. Comparing these results with those obtained by LC methods, no significant differences are found.
Yagci and co-workersd elineate as trategy involving the use of an oncompetitive assayf ormatb yu sing ab iomimetic material, poly(phenylene)b-cyclodextrin poly(ethylene glycol)( PPP-CD-g-PEG), to recognize cocaine due to the affinity of b-CD toward this drug ( Figure 5 ). [29] The authors prepare test strips composed of ap olyvinyl chloride (PVC) backing card, the sample pad, the conjugate release pad, an itrocellulose membrane,a nd an absorbent pad. In the absorbent pad, there is a conjugated pad [containing absorbed antibenzoylecgonine antibody/AuNPs (Anti-BE/AuNPs)],acontrol line (containing absorbed Anti-IgG antibody), and atest line (containing absorbed PPP-CD-g-PEG). Upon applying aliquid sample without cocaine to the sample pad and upon reaching the conjugate pad, the Anti-BE/AuNPs migrate forward together with the liquid sample to give ar ed negative line. If cocainei sp resenti nt he sample, cocainem olecules interact with the b-CD residues in the test line and another red line appears in the test zone as a result of the attachment of the Anti-BE/AuNPs to cocaine. The test resultsc an also be analyzed by using am obile phone application by photographing the strips and evaluating the color group and color percentage in the image. Ag ood linear trend in the 0.01-1.0 mgmL À1 range is observed. Moreover,t he authors find that the sensori ss electivef or cocaine in the presence of benzoylecgonine, nicotine, cotinine,c odeine,t etrahydrocannabinol, and methamphetamine. Finally,t he authors demonstrate the validity of the test stripes by determining cocaine in synthetic saliva with nearly the same accuracy as that achievedb yu sing chromatographic methods.
Simon's reagent (a mixture of sodium nitroprusside, sodium carbonate, and acetaldehyde) is ac hromogenict est used for the detection of alkaloids( containing secondary amines). The amine moiety of the alkaloids reacts with acetaldehyde to yield an enamine, which subsequently reacts with sodium nitroprusside to generate an immonium salt. Finally,t his is hydrolyzed to ab right cobalt-blue product (known as the Simon-Awe complex)t hat allows for the identification of drugs containing secondary amines. Chooduma and co-workers use this reagent to sense methamphetamine by using mobile phone technology. [30] In their study,t he samples (containing methamphetamine) are kept in an opaqueb lack corrugated box and are treated with Simon's reagent;t he intensity of the colored product inside the microtubei st hen detected by using the ColorAssista pp (FTLapps,Inc.) for an iPhone 4.0 in the flash-off mode. The authors relate the RGB values obtained to the concentration of methamphetamine andt hen compare the data with the gas chromatography data. The authors note that the correlation between both sets of data, in terms of methamphetamine concentration,i sr emarkable. Besides, one year later,t he same authors report the entrapment of Simon's reagent into as ol-gel matrix and include it in the corrugated box. [31] For sample analysis, the solid sensor is pierced and methamphetamine is puti nside to allow the reactionb etween the analyte and the reagent. The samples are then directly analyzed by using the same app by studying the RGB values.
To rroba and co-workersd escribe the synthesis of new bis-diarylurea-based probe 21 ( Figure 6 ) for the detection of MDMA from ecstasyt ablets. [32] DMSO solutions of probe 21 show a weak emission band centered at l = 517 nm upon excitationa t l = 288 nm. The addition of aqueous solutionso fe phedrine, pseudoephedrine,a mphetamine, 3,4-methylenedioxyamphetamine, and 3,4-methylenedioxymethamphetamine induces a marked emission enhancement at l = 517 nm due to the formation of a1 :1 stoichiometry complex of ac harge-transfer nature.I ns pite of the fact that the fluorogenic response of probe 21 towards elected drugs is unselective, principal component analysis (PCA) score plots allow their discrimination. Besides, MDMA has been detected in as imulated tablet of ecstasy.N oi nterference is observedi nt he presence of excipients (e.g. sucrose, chalk, or caffeine) in ecstasy tablets.
Cheng and co-workers give details on the preparation of molecular probe 22 containing thiophene heterocyclesa nd a fluorene moiety (Figure7)a nd also polymer 23 containing the same functional groups for methamphetamine( MA) vapor detection. [33] Films of the molecular probe and the polymer are obtainedb ys pin coating. The prepared films are weakly fluorescent,b ut in the presence of MA, am arked emission enhancement is observed for both sensing materials. The weak emission of the films is ascribed to ah eavy-atom effect from the sulfur atom of the thiophenet ot he fluorene fluorophore. In the presence of MA, the reactiono fi ts amino groups with the thiophener ings of compounds 22 and 23 induces a marked reduction in the heavy-atome ffect with as ubsequent emission enhancement. Limits of detection of 1.9 and 6.4ppm for MA by using films containing 22 and 23 have been measured. Besides, exposure of the films to vapors of propylamine, aniline,o rt oluidine induces negligible changes in the emission intensity.
Following as imilar concept, Fang and co-workers design a peryleneb isamide-containingf ilm for methamphetamine vapor detection. [34] Molecular probe 24 (Figure 8 ), containinga peryleneb isimide fluorophore and two cholesterol subunits, is able to form self-assembly fluorescent films on ag lass surface. Ab road emission band at l = 678 nm is observed for the film that is absent in the probe alone.T his emission can be ascribed to the formation of fluorescent aggregates of the probe within the film (through p-p interactions).T his emission band of the film is markedly quenched in the presence of methamphetamine vapor with al imit of detection of 5.5 ppb. Vapors of aniline,x ylidine, o-toluidine, and 1,4-diaminobenzenea lso induce moderate emission quenching. Moreover,t he authors demonstrate that the film can be easily reusedb yp urging with cold air.
Lozano-Torres and co-workers recountt he preparation of mesoporoussilica nanoparticles (MSNs)capped with pseudorotaxanesf or the selectivea nd sensitive fluorogenic detection of MDMAi nw ater (Scheme 4). [35] In af irst step, the external surface of the MSNs is functionalized with an aphthalene derivative, and this is followed by the encapsulationo ff luorescein inside the porousn etwork of the inorganic scaffold. In a second step, the loaded MSNs are capped upon the addition of the cyclobis(paraquat-p-phenylene) hexafluorophosphate ([CBPQT][PF 6 ] 4 )m acrocycle, which forms inclusion complexes with 1-naphtol subunitsa ttached onto the externals urface of the nanoparticles. Aqueous suspensionsoft he nanoparticles at pH 7.0 show negligible fluorescein release, whereas in the presence of MDMA am arked emission band at l = 520 nm (l ex = 495 nm) in the solution is found. Theo bserved emission band can be ascribed to the release of fluorescein from the nanoparticles due to the preferential coordination of MDMA with the CBPQT 4 + macrocycle, which results in pore opening and cargo delivery.B esides, the prepared material is selective to MDMA, and other common drugs (e.g. cocaine, heroin, methadone, and morphine) are unable to induce the release of fluorescein. Al imit of detection of 4.9mm forM DMA in water has been determined.
He and co-workersd etail the synthesis and characterization of an amine-functionalizedp olyfluorene for the detection of methamphetamine. [36] THF solutions of the prepared polyfluorene show two broad emissionb ands at l = 417 and 440 nm (upon excitation at l = 388 nm) due to the fluorene core. The addition of methamphetamine induces am arked quenching of the emission bands (80 %u pon the addition of 40 mm drug), which can be ascribed to an aggregation process of the poly- mer.F romt he emission titration profiles, al imit of detection of 25 ng mL À1 of methamphetamine hydrochloridei sn oted. Other drugs such as pethidine and ephedrine also induce marked quenching of the emission.
Prodi, Dalcanale, and co-workers report the preparation of silica nanoparticles with pyrene derivative 25 inserteda nd with ah ydrophilic externals urface due to the presence of a poly(ethylene glycol)s hell for MDMA detection in water ( Figure 9 ). [37] Aqueouss uspensions of the prepared nanoparticles present the typicalm onomer/excimer emission spectrum of the pyrene fluorophore with bandsa ta bout l = 395 and 475 nm. Upon the incorporation of cavitand 25 into the hydrophobic compartment of the nanoparticles, both pyrene units are in closes patial proximity,w hich allows the formation of an excimer (band centered at l = 475 nm). The addition of increasingq uantities of MDMA induces progressive and marked quenching of only the excimer band. The authors ascribe this fact to the inclusion of the amine moiety of MDMA into the cavitand, which induces spatial separation of both pyrene fluorophores anddisrupts initial excimer 26.The addition of 3-fluoromethamphetamine (FMA) also induces excimer emission quenching but to al esser extent than that observed for MDMA. Amphetamine, glucose, glycine, and sarcosine are unable to induce any emission change. García-EspaÇaa nd co-workers report the synthesis of macrocyclic probes 27 and 28 ( Figure 10 ) containing fluorene and naphthalene fluorophores and their sensing behaviors towards amphetamine sulfate (AMPH), methamphetamine hydrochloride (METH), 3,4-methylenedioxymethamphetamine hydrochloride (MDMA), and dopamine (DA). [38] Aw ater/methanol (7:3, v/v,p H7.4) solution of probe 27 shows typical fluorene emission bands at l = 377,3 96, and 416 nm. The addition of AMPH, METH, MDMA, and DA to as olution of 27 induces am arked emissione nhancement that is nearly of the same order fort he four drugs and ascribed to the formation of 1:1a dducts. In contrast, more selectiveb ehavior is found with naphthalenebearing probe 28.I nt his case, aw ater/methanol (7:3, v/v, pH 7.4) solution of 28 shows the typical naphthalene emission band that is enhanced only upon the addition of MDMA and DA.
Ishii and co-workers presenta no ptimized version of ap reviously published method [39] for the detection of MDMA,M DA, and relatedd rugs that consists in ar apid colorimetric reaction with chromotropic acid (CTA) in 75 %( w/v)a queous sulfuric acid at room temperature (Scheme 5). [40] In this protocol, formaldehyde (33)i sg enerated by treating MDMAw ith sulfuric acid. Then, formaldehyde induces the couplingo ft wo CTA molecules to yield red-violet product 34 that can be examined visually or by measuringi ts absorbance at l = 570 nm. The band at l = 570 nm gradually increases with an increase in the drug concentration. The optimal concentration of CTAa nd the optimal reactiont ime are 1.0 mm and 30 min, respectively, whereas the drug concentration should not be greater than 100 mm to avoid nonspecific color development. Finally,s eized tablets containing well-known concentrations of both MDMA and MDA have been processed and analyzed by using the proposed methodology.
Haghgoo and Rouhanidescribe the synthesis of 1,8-naphtalimide-thiophene derivative 35,w hich is further attached to silica nanoparticles to give 35@SiO 2 . [41] To luene solutions of 35 present ab road emission band centered at l = 435 nm, which shifts to l = 473.5 nm if grafted onto silica nanoparticles. The addition of methamphetamine to as olution of probe 35 ( Figure 11 )o rt oasuspension of the nanoparticles (using toluene in both cases) induces marked emission enhancements (7.3 and 15.4-fold for free 35 and 35@SiO 2 ,r espectively). These emission enhancements can be ascribed to inhibition of the heavy-atome ffect (from the thiophener ing) upon coordination of the probeswith methamphetamine. In contrast, negligi- as o-toluidine, hexylamine, diethylamine, dibutylamine, allylamine, and trimethylamine, whereas slight quenching is found for aniline. Furthermore, methamphetamine vapor sensitivity has successfully been evaluated by exposing analyte-saturated vapors (6.7 mmol L À1 to 0.27 mmol L À1 concentration) over 35@SiO 2 on glass, which shows reversibility after vapor removal. Finally,t he proposed probe has been validated with HPLC, and there is satisfactory agreement between the results obtained with both methods.
Maue and Schrader outline the design and synthesis of a new family of catecholamine probes( i.e. compounds 36-38) combining bisphosphonate recognitionm oieties (for amino alcohols) and boronic acid groups (for the recognitiono fc atechols) in one chemical structure. [42] The addition of alizarine red-S to aqueous solutions of the three probes induces a marked color change from deep red (free dye with an absorbance band at l % 520 nm) to orange (band centered at l = 460 nm) due to the formation of 1:1c omplexes (Figure 12 ). In the presence of noradrenaline, am arked decrease in the band at l = 460 nm is observed together with an increasei nt he absorbance at l = 520 nm (color change from orange to deep red). These changes in color can be ascribed to preferentialc oordination of noradrenaline with the probest hat displace alizarine red-S from the sensing ensemble to the solution.Several potentiali nterferents have been examined, and no positive response for simple biogenica mines (creatinine), sugars (e.g. glucosamine, glucose, fructose, saccharose), neurotransmitters (e.g. g-aminobutyric acid, serotonin, acetylcholine), and amino acids (e.g. serine, phenylalanine, alanine, histidine, lysine,t ryptophan, glycine) is observed.
Basavaiah and co-workersd esign as pectrophotometric methodf or the determination of six phenothiazine drugs (i.e. chlorpromazine hydrochloride, promethazine hydrochloride, trifluoromazine hydrochloride, trifluoperazine hydrochloride, thioproperazine mesylate, and prochlorperazine mesylate) in pharmaceutical preparations. [43] This method is based on the oxidation of the drugs in sulfuric acid mediumb yaknown excess amounto fc hloramine-T.T hen, the excess amount of chloramine-T reacts with 4-N-methylaminophenoli nt he presence of an aromatic amine to produce ap urple-red product with an absorption maximum at l = 520 nm. Inwang and Mosnaim report the development of an efficient and specific extraction proceduref or the UV spectrophotometric detection of 2-phenylethylamine (PEA) through reaction with ceric sulfate( CeSO 4 )t of orm af luorescent probe. [44] Samples are treated with CeSO 4 and HCl in n-hexane, and this is followed by filtration and extraction of the aqueous layer.T his procedure has also been evaluated for biological samples, in addition to real human, cat, and rabbit organs as well as urine. Al inear relationship is found between the concentration of PEA and the UV absorbance at l = 287 nm, with al imit of detection of 0.1 mgmL
À1
. Wang and co-workers discusst he development of two fluorescence chiral sensorsf or the enantiomeric recognition of dand l-a-phenylethylamines (Figure 13) . [45] The author prepared HNMR spectroscopym easurements. El-Didamonya nd Gouda report on the development of a spectrofluorometric method for the detection of pseudoephedrine (41)i nc ommercial pharmaceuticalf ormulations in pure and dosage forms through its derivatization with 4-chloro-7-nitrobenzofurazan (42)(Scheme6). [46] Compound 42 itself is nonemissive but upon reactionw ith thiols or amines,i tf orms highly fluorescent product 43.I np hosphate-buffered saline (PBS, pH 7.8), 41 reacts with 42 to yield as trongly emissive derivativewith ab and at l = 532 nm. The authors optimize several parameters such as pH, buffer,c oncentration, solvent, and temperature finally to proposeamethod that can measure concentrations of 41 down to 0.5 mg mL À1 with good accuracy and precision.
Poryvkina and co-workersv alidate an ew procedure for the detection of several common street drugs such as cocaine, MDMA/MDA, and heroine/morphine on the basis of spectral fluorescences ignature (SFS) measurements and artificial neuron networks (ANNs). [47] SFS analyses generateatwo-dimensional spectra matrix for which the intensity depends on the excitation/emission wavelengths and the concentrationo f the analyte. For cocained etection, the fluorescence emission intensity at l = 315 nm can be evaluated (l ex = 235 and 273 nm) with an enhancement and quenching in the presence of cocaine salt. On the other hand, the MDMA fluorescence emission intensity at l = 320 nm (l ex = 235 and 285 nm) is enhanced if the drug is present. To differentiate MDMA from MDA, the samples can be treated with o-phthalaldehyde-Nacetylcysteine (OPA-NEC), which forms selectively an isoindole complex with MDA with am aximum emission at l = 425 nm (l ex = 335 nm). On the other hand, heroin analysisi sb ased on the detection of morphine in the sample due to the great similarity of their corresponding structures. The fluorescenceo f heroin in water is not strong enough to confirmt he presence of heroin in multicomponent samples, but the presence of morphine can be detected because of its high quantumy ield of fluorescence. For this purpose, samples are treated with hydrochlorica cid to convert morphine into the morphine salt. Growth of the fluorescences ignal is observed at l = 345 nm (l ex = 285 nm) after treatment.T he designed protocol shows excellents electivity and limits of detection. Besides, 98.7 %o f samples are correctly identified, assuringt he robustness of the method.D ue to the great amount of data generated, the use of ANN as at ool for pattern recognition of SFS is required, which includes alearnings tep and posterior validation.
One of the most extensive strategies for the fluorogenic and chromogenic detection of drugs is based on aptasensors, which are ac lass of biosensor systemsb ased on the use of DNA or RNA aptamersa sr ecognition sites. Aptamers can recognizes electively certaint arget molecules through the formation of as pecific three-dimensional site obtained due to nucleotide chain folding. [48] Aptasensors usually show very high sensitivity,s pecificity,a nd reproducibility against aw idev ariety of targets.
As an alternative to traditional chemosensors for methamphetamine (MA) detection, Shi and co-workers present a simplec olorimetric assay for the sensitive and visual detection of this drug in both aqueous solution andh uman urine. [49] The proposed strategy comprises the advantages of using as elective methamphetamine aptamer (as the recognition element) and unmodified easy-to-prepare AuNPs (as an indicator). In a first step, citrate-coated AuNPsa re prepared, and then, the cocaine aptamer is adsorbed onto the externals urfaceo ft he nanoparticles. An aqueous solution of the aptamer-coated AuNPs shows the characteristic plasmon absorption band at l = 525 nm (red color), which is indicative of the presence of nonaggregated individual nanoparticles. The addition of increasinga mounts of methamphetamine induces the progressive appearance of an absorptionb and centered at l = 660 nm with as ubsequent color change from red to blue. This change in color can be ascribed to coordination of methamphetamine with the coating aptamer,w hich induces aggregation of the AuNPs (Figure 14) . Using acalibration curve,the reported aptasensor is able to detect methamphetamine in aqueous solutions at concentrations ranging from 2t o1 0mm with al imit of detection of 0.82 mm.T he aptasensor is also able to detect methamphetamine in urine with recoveries ranging from 96.0 to 107.0 %a nd with high selectivity against potentialc ompeting alkaloids such as pethidine, triazolam, barbital, morphine, ketamine, and diazepam.
Li et al. outline the construction of ac olorimetric methamphetamine probe consisting of aG -quadruplex-hemin DNAzyme molecular beacon, ad rug aptamer,a nd ac olorimetric substrate ( Figure 15) . [50] In the presence of methamphetamine, the DNAzyme dissociates because of strong interactions between the drug and its aptamer,a nd this resultsi nt he formation of aG -quadruplex-hemin complex with peroxidase activity that catalyzes the oxidation reactiono f2 ,2'-azinobis(3-ethylbenzothiozoline)-6-sulfonic acid to yield al ight-green derivative with an absorbance band at l = 415 nm. The proposed aptamer-based probe shows excellent linearity with the methamphetamine concentration and al imit of detectiono f0 .5 nm. The selectivity with 15 other illicit drugs or metabolites (i.e. ketamine, norketamine, morphine, methadone, cocaine, mephedrone, cathinone, methcathinone, 3-trifluromethylphenyl piperazine, 1-(3-trifluromethylphenyl)piperazine, 3,4-methylenedioxypyrovalerona,M DA, MDMA, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, and meta-chlorophenylpiperazine) has been evaluated, yet none of them show as ignificant UV/Vis response.
Willner andc o-workersr eport the design of an aptamerbased nanomachine for the fluorogenic detection of cocaine. [51] The nanomachine contains three regions: 1) ac ocainea ptamer;2 )a nicking site for endonuclease (Nt.BbvCI); 3) at ransductionr egion (Figure 16 ). Initially,t he aptamer recognizes the cocainem olecule, and then,i nt he presence of polymerase and 2'-deoxynucleosidetriphosphates (dNPTs), the complementary strand is synthesized (see Figure 16 b ). Then, region 2i s nickedb yN t.BbvCI endonuclease, and this is followed by a cyclic processb yw hichthe complementary region is repeatedly polymerized with the aid of the polymerase enzyme. The released transduction region (see Figure 16 d ) hybridizes with its complementary strand, which separatest he two fluorophores (i.e. carboxyfluorescein and 5-carboxytetramethylrhodamine) and forbids the fluorescencer esonance energy transfer (FRET) process to which they were submitted. Finally,alimit of detection of 5 10 À6 m for cocainecan be achieved. The same authors have also created an amplified aptamer sensorf or cocaine (Figure 17) . [52] The developed system is formed by three domains:1 )adomain that corresponds to the cocainea ptamer, whichi sb lockedb yt he complementary strand;2 )a domain containing an icking strand;3 )the transductionr egion.I np resence of cocaine, the system begins the replication and nicking processes;t his releases domain 3, which is complementary to the strand containing af luorophore and aq uencher (off state).T hen, the DNAzyme cleaves the fluorophore/quencher to yield the fluorophore-labeled strand (separatedf rom the quencher) that provides the readout signal for the analysisofc ocaine (on state). The limit of detection for cocaine is 0.1 mm.F inally,amethod for amplified cocained etection has been developed by the coupling of a second replication/nicking system that includes an autono- Wang andc o-workersv alidate the use of af luorescence label-free aptasensor for detecting cocaine in complex biofluids. [53] The system consists of an aptamer and two fluorophores,2 -amino-5,6,7-trimethyl-1,8-naphthyridine (ATMND) and SYBR Green I( SGI), whichs erve as as ignal reporter and a built-in reference, respectively.B oth fluorophores interact strongly with the aptamer,a nd as ac onsequence, their fluorescence is quenched. However,i fc ocainei sa dded, an enhancement in the fluorescencee mission of ATMND is observed. This emission enhancement can be ascribed to the fact that ATMND coordinates with the binding cavity of the aptamer and is displaced in the presence of cocaine. The authors report alimit of detection of 56 nm.The system has been tested in biofluids (e.g. saliva, serum, and urine) with fine results.
Huang and co-workers detail the design of an ew system based on as trand-displacementp olymerization reaction by using aptamer recognitionf or the detection of cocaine (Figure 18) . [54] The system consists of ah airpin probe labeled with Cy5 (acceptor fluorophore) on its 3'-end and containing the cocaine aptamer sequence, ap rimer derivatized on its 5'-end with carboxy fluorescein( ad onor fluorophore), and a polymerase (which induces DNA sequence synthesis). If cocaine is present, the hairpin probe recognizes the drug and the polymerase induces DNA synthesis;t his resultsi np roximity between the donor and acceptorf luorophore, which leads to af luorescencee nhancement. The limit of detection for cocaine is 20 nm.F inally,t he authors also evaluatet he systems in the presence of benzoylecgonine and ecgonine methyl ester. Neither of the tested interferents induce emission changes.
Johnson and co-workers discuss the development of an aptameric cocaine sensorb ased on FRET between quantum dots (QDs) and the fluorophore Cy5 (Figure 19) . [55] For this purpose, QDs coated with streptavidin are functionalized with the single-stranded DNA sequence 5'-TCA CAG ATGA GT-biotin-3'. Then, the cocainea ptamer is sandwiched between this oligomer and 5'-GTC TCC CGA GAT-Cy5-3'.U pon excitation of the QDs at l = 605 nm in an aqueous suspension of the sensor,t he typical emission band of the Cy5 fluorophore at l % 675 nm appearsd ue to the presenceo faFRET process between the nanoparticles and the fluorophore. However, in the presence of cocaine, the random-coil aptamer changes to ah airpin conformation,w hich releases the Cy5 fluorophore brand with subsequent suppression of the FRET process. As ac onsequence, the emissiono fC y5 is progressivelyq uenched depending on the amounto fc ocaine added. The limit of detection for cocaine is 0.5 mm,a sd eterminedb yatitration profile. Besides, the authors modify the probe to obtain an emission enhancement as output.F or this purpose, they include aC y5 quencher into the probe structure. The surfaceo ft he QDs is functionalized with 5'-Cy5-TCAC AG ATGA GT-biotin-3'.T he cocaine aptamer is again sandwiched between this oligomer and 5'-GTC TCC CGA GAT-Iowa Black RQ-3' containing aq uencher of Cy5. The presence of the quencher inhibits the FRET process between the QDs and Cy5. In the presence of cocaine, the quencher oligomer is released due to ac hange in the aptamer to the hairpin conformation and the FRET process occursw ith as ubsequentt urn-on response. The limit of detection for cocaine is 0.5 mm,a sd etermined by atitration profile. Abnous and co-workersm erge two different types of nanoparticles to construct an aptasensor for the fluorogenic detection of cocaine. [56] The authors first prepared silica nanoparticles coated with streptavidin and functionalized with 5'-fluorescein-ATT GAA GGA TTT ATCC TT GTC TCC CTATGC TTC AATbiotin-3' (complementarys equence to that of the cocaine aptamer). On the other hand, they also prepare AuNPsf unctionalized with the 5'-CCA TAGG GA GAC AAG GATA AA TCC TTC AATG AA GTG GGT CTC CC-thiol-3' sequence containing the cocaine aptamer.U pon mixing both nanoparticles, the complementary strandsh ybridize, and the emission of fluorescein is quenchedb ecause the fluorophore is in close proximity to the AuNPs. The addition of cocaine induces dehybridization of the double-stranded DNA fragment duet od rug-aptamer coordination.T his process detaches both types of nanoparticles, and as ac onsequence, fluorescein emission is restored. Besides, the limits of detection of cocaine in water (209 pm) and serum (293 pm)h ave been determined. Thea uthors find that chloramphenicol, propranolol, and diazepam are unable to induce any emission enhancement, whereas morphine yields the same response as cocaine.
Xiao et al. reportalabel-free aptamer-fluorophore ensemble to detectc ocaine. [57] The authors observe that the typical aptamer used to recognize cocaine is able to complext he fluorophore 2-amino-5,6,7-trimethyl-1,8-naphthyridine (44) ( Figure 20 ). Due to complexation, fluorescenceo f44 is quenched. However,i nt he presence of cocaine, the complex between the aptamer and the fluorophore is disrupted, and an emission enhancement is observed. The authors note al imit of detection of 200 nm in water.B esides, the sensing ensemble allows the selective detection of cocaine in the presence of its metabolite benzoylecgonine. In urine and saliva, the aptasensorp resents limits of detection of 460 and 520 nm,r espectively.
Coskunol et al. create an aptamer-folding-based sensing device for cocained etection. [58] Poly-l-lysine-coated microwells are used as inorganic supports andQ Ds functionalized with carboxylic acidg roupsa re grafted onto the surfaceb yu sing N-hydroxysuccinimide (NHS)/1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC). On the other hand, AuNPs functionalized with the cocaine aptamer sequence 5'-NH 2 -C6-AGAC AA GGA AAA TCC TTC AATG AA GTG GGT CG-C3-SH-3' are anchored to the QDs also by using NHS/EDC. In the absence of cocaine, strong fluorescencef rom the QDs is observed, whereas in the presence of the drug, this emission is quenched (Figure 21 ). Thisemission quenching can be ascribed to coordination of the aptamer to cocaine, which brings the QDs close to the AuNPs with subsequent fluorescence deactivation. The same response is observed for benzoylecgonine. The limits of detection for cocaine and its metabolite are 0.138 nm and 1.66 mm,r espectively.T he aptasystem is selective for cocaine and benzoylecgonine in the presence of methamphetamine, 3-acetamidophenol, and codeine.F inally,u pon analyzing synthetic urine samples containing cocainea nd benzoylecgonine with the sensing material and comparing the results with those obtained by traditional HPLC methods, no significant differences are found.
Martínez-MµÇez and co-workersi mplement "molecular gates" onto nanoporous anodic alumina (NAA) to prepare a sensingm aterial for cocaine detection (Figure 22) . [59] The NAA support, obtaineda ccording to reported procedures, [60] is loaded with rhodamine Ba nd functionalized with (3-isocyanatopropyl)triethoxysilane. Then, the amino-terminal DNA sequenceN H 2 -(CH 2 ) 6 -5'-AAA AAA CCC CCC-3' is covalently linked to the surface by the formation of ureab onds. In af inal step, the pores are capped with the 5'-TTT TGGG GG GGG GAG ACA AGG AAA ATCC TT CAA TGA AGT GGG TCT CCA GGG GGG TTT T-3' sequence, which specifically hybridizes with the short DNA fragment attached to the externals urfaceo fN AA and contains the cocainea ptamer.I ft he sensing materiali si mmersed in Tris solution (pH 7.5) without cocaine, negligible dye releasei so bserved.H owever,i nt he presence of the drug, marked rhodamine Bd elivery is found (reaching 100 %a fter 50 min). Using a calibration curve obtained upon adding increasing amounts of cocaine, al imit of detection of 5.0 10 À7 m is calculated. Besides, the material presentsg ood selectivity for cocaine, and no response is observed by exposing it to other drugs such as morphine and heroine. Finally,t he sensorh as been validated in saliva. The same research group has developed ah omologous nanostructured system for the detectiono fc ocaineb y surface-enhanced Ramanspectroscopy (SERS). [61] Landry and co-workersoutline the development of acocaine sensorb ased on the assembly of fluorophore-labeled heterodimeric aptamersi nt he presence of the analyte. [62] The authors preparet wo oligonucleotides containing the cocainea ptamer sequence. One of the oligonucleotides is labeled with a5 '-carboxyfluorescein fluorophore, whereas the other is functionalized with the well-known fluorescence quencher dabcyl at the 3'-position. In the presence of cocaine in ab uffered solution and with optimal oligonucleotide chain concentration, heterodimerization of both aptameric sequences results in fluorescein emission quenching at l = 518 nm (Figure23). This sensor has al imit of detection of 1 mm and has excellent selectivity,a sn o quenching effecti so bserved in the presence of the cocaine metabolites benzoylecgonine and ecgonine methylester.
The same authors have also engineered an ew method for the detection of cocaine in serum by using ad eoxyribonucleotide-based aptamer (Figure 24) . [63] The proposed method consists of an aptamer that is designed taking into account that binding with cocaine induces am arked change in its secondary structure and, as ac onsequence, in the emission of a graftedf luorophore. The authors construct ad ouble-labeled aptamerw ith 5'-fluorescein as the fluorophore and 3'-dabcyl as the quencher.I nt he absence of cocaine, both the fluorescein and quencher are far away,a nd excitation of the fluorophore results in its emission at l = 518 nm. However,i nt he presenceo fc ocaine,t he aptamer changes its conformation upon coordination with the drug, and thus, the fluorophore and quencher come into close proximity.A sac onsequence, the emission of fluorescein is quenched. The aptamer allows the detection of cocainei nt he 10 mm to 2.5 mm range. Finally, the authors demonstrate that the sensor is highly selectivef or cocaine and is useful for the screening of cocaine hydrolases.
In 2002, Landry and Stojanovic developed another cocaine sensort hat consists in the displacemento facyanine dyef rom the hydrophobic pocket generated by anticocaine aptamer MNS-4.1 upon bindingw ith the drug (Figure 25) . [64] The authors screen 35 different dyes to find one that displays both significant attenuation of absorbance andachange in the ratio of two relative maxima. Thus, the authors select diethylthiotricarbocyanide dye and mix it with the aptamerM NS-4.1 in a buffered media. Then, increasing concentrations( 2t o6 00 mm) of cocainea re added, and ad ecrease in the absorption at l = 760 nm is observed (whereas the absorption band at l = 670 nm remains unaltered). Negligible changes in the visible spectra are found upon adding the cocaine metabolites benzoylecgonine and ecgoninem ethyl ester (up to 2mm). Finally, marked color changes (from colorless to blue) are observed upon using higher dye and aptamer concentrations( 40 and 20 mm,r espectively)i nt he presence of 500 mm cocaine. Recently,L iu and Zhao presented an aptasensor labeled on as pecific position at one Gb ase with the tetramethylrhodamine (TMR) fluorophore that is able to detect cocainei na queous environments. [65] In the absence of cocaine, the labeled aptamer adopts ac onformationi nw hich TMR interacts with the surrounding guaninen ucleotides.A saconsequence of these interactions, TMR suffersf rom restricted freedom, which is reflected in high fluorescencea nisotropy (unequal intensities along different axes of polarization).H owever, upon binding of cocaine to the aptasensor there is ac hange in the conformation anda lso an alteration in the TMR-guanine interactions, which is reflectedb yadecrease in the fluorescencea nisotropy ( Figure 26 ). The best fluorescencea nisotropy changes are obtained in the pH range of 7.0 to 8.5 at 10 8C. Moreover, the presenteda ptasensor allows the direct detection of cocainew ith al imit of detection of 5 mm and also enables the detection of The system has also been tested against theophylline,c affeine, bovine serum albumin,i mmunoglobulinG,a nd af ew amino acids, including arginine, phenylalanine, and aspartic acid. No remarkable fluorescencec hanges are observed, even at high concentrations.
Dong and co-workers delineate the development of a simple and easy to prepare colorimetric aptasensor for cocaine detection in aqueous solutions. [66] Double-stranded (ds) DNA can act as an efficient template for the formation of highly emissive coppernanoparticles (CuNPs) by using low concentrations of CuSO 4 .H owever, the ssDNA template does not support the formation of CuNPs. The design consists of the use of two ssDNAs equences, one of them the cocaine aptamer and the other its complementary counterpart. Both sequences hybridize to form dsDNA, which acts as at emplate for the formation of fluorescent CuNPs in the presence of CuSO 4 .H owever, in the presence of cocaine, the dsDNA dehybridizes due to the selectiveb inding of the aptamer sequence with the drug, which precludes the formation of the emissive CuNPs ( Figure 27 ). Other analgesic drugs (e.g. pethidine and methadone) and the complete hydrolysate form of cocaine (ecgonine) induce negligible responses. Besides, this aptasensor shows ag ood linear relationship in the presence of cocaine with alimit of detection of 0.1 mm.
Li's group outlines the development of as ystem for the detectiono fc ocaineb ye mploying ac ocainea ptamera sarecognition site, graphene oxide (GO) as the fluorophore, and gold nanoparticles (AuNPs) as the quencher. [67] The cocainea ptamer is divided into two differentf ragments,C 1a nd C2, that are covalentlyi mmobilized onto GO and the AuNPs, respectively.I n the presence of cocaine, aptamers C1 and C2 hybridize. This induces spatialp roximity between the AuNPs and GO with subsequente missionq uenching of the latter (Figure 28 ). With this simple aptasensor,t he limit of detection for cocaine is 0.1 mm.T he system works well in biological fluids such as plasma and serum. Moreover,t he authors find that 0.1 mm cocaine leads to fluorescence quenching, whereas no effect is observed in the case of pethidine and methadone, even at concentrations as high as 50 mm (500 times the concentration of cocaine).
As imilarG O-based aptasensor for cocained etection by using cocaine-selective aptamersi sa lso reported by Zhang and co-workers (Figure 29 ). [68] Fan and co-workerspresent abioassay strategy to detect cocaine on the basis of AuNPs and modified DNA aptamers. [69] In this design, the cocaine aptamer is divided into two pieces that present random-coil-like conformations( ACA-1a nd ACA- 2). In the absence of cocaine, ACA-1 and ACA-2 spontaneously bind with the AuNPs,which stabilizes the AuNPs and precludes them from undergoing aggregation.C onsequently,t he typical plasmon band centered at l = 520 nm and ad ark red color are observed. However,i nt he presence of cocaine, the solution turns blue (absorption band at l = 650 nm) due to the formation of at ertiary structure between ACA-1, ACA-2, and the drug, and this results in aggregation of the AuNPs (Figure 30 ). Using this strategy,c ocainei nt he low-micromolar range can be selectively detectedb yt he naked eye. Thel imit of detection for cocaine is as low as 2 mm.
Liu and co-workersr eport as imilara ptasensor for cocaine detection by using aptamersp reviously immobilized on the surfaceofA uNPs (Figure 31 ). [70] Zou and co-workers also use the combination of AuNPs and at riple-fragment aptamer for the selective opticald etection of cocaine. [71] In the absence of cocaine,t he three aptamer fragments interact with the AuNPs,w hich prevents their aggregation, and as ac onsequence, the solution remains red. In the presenceo fc ocaine, the three aptamerf ragments bind with the drug, leaving the AuNPs to form aggregates (Figure32) with ac olor change to blue. The system is selective to cocaine, and no response is found in the presence of ecogonine methyl ester and benzoylecgonine. This aptasensor shows ag radual color change from red to blue as the concentration of cocaine is increased from 0t o2 00 mm.Ac oncentration of 100 mm cocaine in humanu rine or serum is readily detected by using this protocol.
Zhang and co-workersd iscuss al abel-free fluorescence aptasensor for cocained etection on the basis of the high affinity of aG -quadruplex for the ruthenium polypyridyl complex Ru-
[72] The authors modify ac ocaine-selective aptamer by extending the originals equence with guanineb ases, which can form an intermolecular G-quadruplex under certain experimental conditions. The authors note that the Ru complex can be successfully embedded into the G-quadruplex structure to increaset he fluorescence. However, in the presence of cocaine, the drug binds selectively to the aptamer,w hich resultsi nd issociation of the G-quadruplex and release of Ru[(bpy) 2 
(bqdppz)]
2 + accompanied by significant emission quenching (Figure 33 ). The fluorescencei ntensity at l = 600 nm decreases upon increasing the concentration of cocainef rom 12 to 1300 nm,a nd the detection limit is as low as 5nm.T his system is highly selective towardsc ocaineo ver other small drugs such as caffeine, morphine, andt heophylline. Furthermore, detection of cocainei n human serum can be performed with recoveries in the 94.5-103.6 %r ange.
An example using modified aptamers grafted onto an optical fiberb iosensing platform for the detection of cocaine is reported by He's group. [73] In this work, ac ocaineaptamer is split into two fragments, and one of them is modified with af luoro- 2 + is disassembled in the presenceo fc ocaine, allowing its detection by emission quenching.
ChemistryOpen 2018, 7,401 -428 www.chemistryopen.org 2018 The Authors. Publishedb yWiley-VCH Verlag GmbH &Co. KGaA, Weinheim phore (Cy3) and the other with aq uencher (BHQ = black hole quencher). In addition, the fluorophore-containing aptamer fragment is extended by 13 bases that can hybridize with an oligonucleotide previouslyi mmobilizedo nt he optical fiber platform.I nt he presence of cocaine, the two fragments quickly form at hree-way junction aroundt he drug, whichp ositions the fluorophore and the quencher in close proximity with subsequent emission quenching ( Figure 34 ). At the same time, the tail of the three-way junction hybridizes with the oligonucleotide sequences immobilized on the opticalf ibers urface, and changes in the fluorescencea re controlled by an evanescent wave. The aptasensor displays ah ighly competitive limit of detection of 165 nm and as ensing concentrationr ange between 200 nm and 200 mm.T he selectivity of this aptasensor has also been investigated against severalc ompounds, including kanamycin, amikacin, and ibuprofen. No signal changes are observed,e ven at high concentrations( 100 mm)o ft hese compounds.T his system can be used to detect cocainei nh uman serum.
Recently,W ang and co-workers have developed an ew cocaine naked-eyed etectionm ethod ( Figure 35 ) by using paper microfluidic strips (PADs) coupled with gold nanoparticles and two cocaine aptamers( ACA-1 and ACA-2). [74] The PADs are fabricated by using ac ommercial waxp rinter to form three chambers (with different diameters) on the surface of chromatographic paper Whatmann No.1. More in detail, the chromatographic strip has, at the upper part, ac hamber that contains 2nmol AuNPs. In the middle chamber,A CA-1 and ACA-2 (0.6 nmol each) are placed.F inally,t here is ac hamber at the bottom of the strip for the samples. After adding the sample in the bottom chamber,t he preparedt est strip is placed in a carrier solution containing 2.8 m MgCl 2 /50 mg mL À1 sucrose (300 mL).Iti sknown that free aptamersc an bind to the surface of AuNPs, preventing them from aggregating even in the presence of concentrated salts (red color). However,i nt he presence of cocaine, these aptamersb ind to cocaine, leaving the AuNPs free to aggregate. The authors find that even at low concentrations of cocaine( 10 mg) the carriers olutionp asses through the aptamer zonet ot he location of the AuNPs and the color changes from pink-red to gray in 5min. In contrast, in the absence of cocaine, the moving solution arrives at the end of the strip and the AuNPs area remains red, which can be noted by the naked eye. The limit of detection for cocaine reportedf or this system is 2.5 mg. Besides, ah igh selectivity over other illicit drugs such as ephedrine, codeine, ketamine, amphetamine, morphine, and methamphetamine can be achieved.F urthermore, metabolites of cocaine,b enzoylecgonine, and ecgonine methyl ester are unable to induce ac olor change.
Liu and Lu present am ethod for the detection of cocaine on the basis of the colorimetric change observed upon disassembly of AuNPs functionalized with different thiol-modified DNA sequences connected to ac omplementary DNA sequence (linker) and to the corresponding analyte aptamer. [75] In the absence of cocaine, gold nanoparticles form aggregates of thousands of nanoparticles (blue color due to an absorbance band centered at l = 700 nm). However,i nt he presence of this drug, these nanoparticles separate from each other because of a conformational change in the aptamer upon binding to cocaine (Figure 36 ), and this changes the color of the solution to red (absorbance at l = 522 nm). Characterization by transmis- sion electron microscopy after/before cocainea ddiction confirms the disaggregation of the nanoparticles. Cocainec an be quantified in the range of 50 (LOD) to 500 mm within a1 0s period.
Liu et al. reported in 2016 ap ortable up-conversion nanoparticle( UCNP)-basedp aper device for cocained etection. [76] The paper device is functionalized with polyethylenimine (PEI)-coated UCNPs and with the amine-modified ACA-1 fragment of the cocaine aptamer. Besides, another fragment of cocaine aptamer (ACA-2) bearing at hiol moietyi sg raftedo nto the external surface of 16 nm AuNPs (Figure 37 ). In the presenceo f cocaine, both DNA fragments (ACA-1a nd ACA-2) reassemble, and the luminescence of the UCNPsi sq uenched by the proximity of the AuNPs.T his quenching effect can be attributedt o the perfect match of the emission of the UCNPs and the absorptiono ft he AuNPs and can be observed by the naked eye for qualitative analysiso rr ecorded by as martphonet oc onvert data into RGB intensity for quantification. The limit of detection for cocaine is 10 nm,w hereas in human saliva the minimum amount detected is 0.05 mm.B esides, recoveries in the 89-103 %r ange can be measured for cocaine-spiked samples of human saliva. On the other hand, neither ecgoninem ethyl ester nor benzoylecgonine induce any emission change.
Yu and co-workersr eport ac ocained etection method based on graphene oxide (GO) and on polymerase-aided isothermal circulars trand-displacement amplification (ICSDA) combined with the use of the dye SYBR Green I( SGI). [77] The authors prepare ah airpin probe consisting of two different DNA fragments:1 )acocainea ptamer;2 )aregiond esigned to hybridize with ap rimer. In the absence of cocaine,t he 3'-phosphorilated end of the hairpin probe oligonucleotide chain avoidsp olymerase elongation, whereas in the presence of the drug ac onformationalc hange exposes the 3'-single-stranded tail that hybridizes with the primer and allows initiation of the polymerase chain reaction. Thisp rocess forms large amounts of dsDNA,w ith low affinity towardG O, which intercalates the SGI dye, and its fluorescencei so bserved. In addition, in the absence of cocaine, dsDNA is not formed, and the hairpin probe and SGI are adsorbed onto GO with subsequentq uenching of the emissiono ft he fluorophore (Figure 38 ). The limit of detection forc ocaine is estimated to be 190 nm,a nd the linear range is from 0.2 to 100 mm.W eak fluorescence emission in the presence of adenosine, caffeine,t heophylline, and morphine hydrochloride is observed. Finally,g ood linear correlation from 0.5 to 100 mm is achievedf or cocaine-spiked real urine samples (20-foldd ilution).
Yagci and co-workersassess ad ouble fluorescencem icrowell assay that combinesQ Ds labeled with cocaine antibodies with ap olyphenylene-based polymer( PPP) containing b-cyclodextrins (CDs) derivatized with poly(ethylene glycol) (PEG) chains ( Figure 39) . [78] The PPP-CD-g-PEG polymer can be synthesized by aS uzukic oupling reaction. In this polymer, the hydrophobic cavityo ft he CD is envisioned as ac ocaine recognitions ite, whereas the PEG chains provide water solubility.T he surfaceo f the microwell is modifiedb yg rafting of the PPP-CD-g-PEG polymer.C ocaine forms inclusion complexes with the CD in the polymericb ackbone. Then, the QDs are added, and they coordinate with cocaine through selectivei nteraction of the drug with the antibodies that coat the nanoparticles. As ac onsequence, the emission of the QDs centered at l = 655 nm (l ex = 400 nm) is enhanced. Besides, the intrinsic fluorescence emissiono fP PP-CD-g-PEG at l = 410 nm (l ex = 330 nm) is quenched by the adsorbed QDs. By using this methodology,a linear range from 10 to 100 nm of cocaine with al imit of detectiono f1 3.35 nm is obtained. Negligible response is obtained in the presence of methamphetamine, codeine, tetrahydrocannabinol, nicotine,c otinine, and benzoylecgonine. Finally, synthetic serum samples spiked with known cocainea mounts have been analyzed, andt he resultso btained have been compared to those obtained by using LC-MS/MS;g ood agreement is observed. Hu et al. present an ovel colorimetric cocaine biosensor based on Au@Agc ore-shell nanoparticles (Figure 40) . [79] For this purpose, Au@Ag nanoparticles are functionalized with a ssDNA reporter (RP), andt hen, magnetic beads (MBs) are prepared and coatedw ith ac aptures sDNA (CP). RP and CP are designed to present complementarity with the cocainea ptamer.I nt he absence of cocaine and in as olutionc ontaining its aptamer, RP-functionalized Au@Ag nanoparticlesa nd CPcoated MBs aggregate and can be removedu pona pplication of an external magnetic field.H owever,i fc ocainei sp resent, its selectivec oordination with the aptameri nhibits nanoparticle aggregation, and the solution remainsy ellow (absorbance of the nanoparticles centered at l = 400 nm). With this protocol, the limit of detection for cocainei s0 .5 nm with al inear response of 0.5 to 200 nm.T he system does not respond to the presence of other illicit drugs such as ketamine,n orketamine, morphine, cathinone, methacathinone, 3-trifluoromethyphenylpiperazine, and MDA. As imilarb iosensor can be prepared for sensing methamphetamine with al imit of detection of 0.1 nm.
Leung and co-workers describe al abel-free switch-on luminescent sensor for the detection of cocaine. [80] The authors design two DNA oligomers composed of af ragment of the cocaine aptamer and af ragment able to form G-quadruplex structures. In the presence of both cocainea nd an iridium complex, the two aptamer fragments came together to allow the formation of aG -quadruplexs tructure, which gives al uminescent response. The ability to form the G-quadruplex structure with different iridium complexes has been studied. The best response is observed with 45 ( Figure 41 ), as the size and shape of the N^N ligand is crucial for constructiono ft he G-quadruplex structure. The limit of detection of the aptasensor with complex 45 for cocainei s3 0nm.B esides, the aptasensor is selective for cocaine in the presence of adenosine triphosphate, adenosine, warfarin, and suramin. Moreover,t he formation of the G-quadruplex structurew ith other planar molecules such as ochratoxin A, thiazoleo range, protoporphyrin IX, crystal violet, thioflavin T, and adenosinet riphosphate has been studied, and only aw eak luminescence response is observed. Du et al. report as imple and sensitive DNAzyme-based colorimetric sensorf or cocaine detection by using the 3,3,5,5-tetramethylbenzidine sulfate (TMB)/H 2 O 2 reaction system. [81] For this purpose, the amino groups of functionalized magnetic nanoparticles (MNPs) are linked covalently to at hiolated cocaine aptamer fragment (C2). On the other hand, another cocaine aptamer fragment is extended with aG -enriched strand AG4 (C1-AG4). In the presence of cocaine, the C2 layer on the MNPs hybridizes partlyw ith C1-AG4 to result in the folding of the aptamer into at hree-way junctiono nt he surfaceo ft he MNPs to form aM NPs-C2-cocaine-C1-AG4c omplex. Using an externalm agnet, the nanoparticles can be separated from the solution (Figure 42) . Then, the addition of hemin to the MNPs-C2-cocaine-C1-AG4 complex promotes the formation of a DNAzyme, which catalyzes the TMB/H 2 O 2 reaction system to yield ac hange in the color of the solution from colorless to yellow.I nt he absence of cocaine, the separated MNPs do not include C1-AG4;t hus, no background signal can be produced. Using these aptasensors,d rug concentrations of 100 nm can be directly detected by the naked eye, with alimit of detection of 50 nm.B esides, this protocol shows high selectivity for cocaine over ecgonine, pethidine, and methadone, which do not induce any color changes.
Silver nanoclusters( AgNCs)c an be used as an indicator for cocained etection in the presence of DNA templates utilizing the advantages of the nicking endonuclease-assisted signaling amplification (NEASA)s trategy( Figure 43) . [82] The reported aptasensorc onsists of three different DNA sequences, DNA1, DNA2, and DNA3. Thef irst one is designed to contain three domains: the cocaine aptamer,asequence that is complementary to DNA2, and an icking endonuclease (Nb.BbvCI) enzyme recognition sequence. On the other hand, DNA2 includes two AgNCs template segments (coordinates with metallic AgNCs) Figure 40 . Schematic illustration of the mechanism for the detection system based on gold nanoparticles core-shell functionalized with aptamers. Finally,D NA3 is designed to be partly complementary to both ends of DNA2. It must be noted that the free AgNC template segments act as as caffold for the synthesis of fluorescent silver nanoclusters in the presence of Ag + through its reduction with NaBH 4 .T herefore, in the absence of cocaine, DNA3 and DNA2 undergo hybridization to form ac losed circular structuret hat keeps the AgNC template segment in ar igid stage that cannotc ombine with Ag + to form the fluorescent silver nanoclusters. However,t he addition of cocainet ot he solution induces openingo ft he structure due to the binding of cocainet oi ts specific aptamer; thus, hybridizationb etween the three DNAs to form aD NA1-DNA2-DNA3 complex is facilitated. Then, selective enzymatic cleavage of the DNA2-DNA3 duplex by Nb.BbvCIr esults in the release of free AgNC template segments, and this induces the synthesis of fluorescent silver nanoclusters. Thea ptasensor shows high selectivity for cocaineo ver other commoni nterferences such as ecgonine and benzoylecgonine. The prepared aptasensor presents a linear range from 2nm to 50 mm cocainew ith al imit of detection as low as 2nm.B esides, the probe is able to detectc ocaine in human serum with very high recovery values of around98t o9 9.8 %.
Zhou and co-workerso utline the construction of an ew optical aptasensor for cocaine detection. [83] The system is based on af luorescein isothiocyanate (FITC)-labeleda ptamert hat produces ac onformational change from ap artial single-stranded DNA to ad ouble-stranded T-junction in the presence of cocaine ( Figure 44 ). This change facilitates am inor-based energy transfer (MBET)b etween the FITC-labeled 3'-end of the aptamer and Hoechst 33342 bound to the double-stranded T-junction, and this leads to fluorescencee mission at l = 520 nm (l ex = 360 nm). The authors test the response of the aptasensor with benzoylecgonine and ecgonine methyl ester.N one of the selected interfering chemicals induce any emission change. Furthermore, the limit of detection for cocaine is 0.2 mm.
Ta king into account the previously exposed works, several strategies have been used to develop chromo-and fluorogenic probesfor stimulant drugs,namely:1)the formation of fluorescent complexes;2 )antibody-based systems; 3) the use of nanoparticles;4 )derivatization reactions;5 )spectral fluorescent signatures;6)aptamer-based methods.
The formation of fluorescent complexes is one of the most exploited strategies.P robes reported within this approach change or enhancet he fluorescencee mission almost instantaneously and are easy to handle;s omeo ft hem have the ability to detect drugs in the vapor phase, which considerably increasest heir potential use as ad etection method in realistic settings.B esides,s ome of them can be fixed over surfaces. However,s ome limits of detection are relativelyh igh, and some of the reported examples work in organic solvents or in mixed aqueous solutions. Several examples have high potential for real applicability.F or instance, sensing strips for the nakedeye detection of cocainebyu sing antibodies and associated to am obile app for quantificationo ft he drug have been described.S ensory systems based on porous nanoparticles loaded with dyes/fluorophores show signala mplification features and allow drug detection in the vapor phase. Chemical derivatization of drugs with the aim to confer fluorescencet o the final molecules is another widely followed strategy.T he used reactions are fast and reliable, and some of the protocols described also include the use of mobile technology.I ns pite of these positive facts, none of the described examples based on this approach can detect drugs in the vapor phase. Other approaches involvet he use of spectral fluorescences ignature (SFS) measurements and artificial neuron networks for data treatment. This approachp resentss ome drawbacks, such as the need for learninga nd validation stepsa nd its complicated translation into an in-field system measurement.M oreover,a large percentage of the published examples dealing with the detection of well-known abuse drugs (such as cocainea nd methamphetamine) are based on the use of aptamers (alone or graftedo nto organic/inorganic supports). The selectivity Figure 44 . Scheme for cocaine detection by using aptamers grafted onto polydimethylsiloxane glass. In the presence of cocaine, the aptamer adopts as pecific conformation that interactswith Hoechst 33342. This dye restores FITC emission. 
Hallucinogenic Drugs
Hallucinogenic drugs include cannabis,p silocybin, lysergica cid diethylamide (LSD), peyote, and dimethyltryptamine (DMT), among others. [84] Historically,s ome of these drugsh ave been used for religiousr ituals. They cause the consumer to see and hear inexistent and unrealt hings, which causes the consumers to feel out of control or disconnected from their body and environment. Specifically, some of their most prominente ffects occur in the prefrontal cortex-ana rea involved in mood, cognition, and perception, as well as other important regions in regulating arousal and physiological responses to stress and panic. These drugs can be found in some plants and mushrooms or can be man made. LSD, psilocybin, and DMT produce their effects through interaction with serotonin (5-HT)r eceptors. Others, the most, affect the N-methyl-d-aspartate receptor (NDMA-receptor), the k-opioid receptor (KOR),a nd the neurotransmitter acetylcholine.
Badout and Andre takea dvantage of the intrinsic fluorescent properties of lisergamide (commonly known as LSD) to develop al ow-costing and portable device for its detection. [85] LSD presents af luorescenceb and in the l = 400-530 nm range, depending on the solvent and pH. The apparatus is constructed to allow the naked-eye detection of LSD by comparing the emission of an LSD solution with its corresponding blank solution upon excitation with am ercury lamp by using both neutral and 1 m NaOH alkali solution as the solvent. If LSD solutionsi nn eutral water are submitted to the mercury lamp, ac haracteristic blue emission is observed. This occurs also with other hallucinogens such mescaline,2 ,5-dimethoxy-4-methyl amphetamine (DOM), psilocin, psilocybin, bufotenin, ibogaine, and phencyclidine. However,i ft hey are dissolved in 1 m NaOH aqueous solution, only with LSD is ac hange in fluorescence emission to green observed. The limit of detection for LSD samples dissolved in neutral water is 50 ng, whereas that for LSD samples in alkali media increases to 260 ng.
There is only one example reported in this section, andi ti s anticipated that new chromo-and fluorogenic probes fort he detection of hallucinogenic drugs will be developed in the near future.
Opiods
Opioidsd rugs such as heroin,c odeine, morphine, fentanyl, hydrocodone, oxycodone, buprenorphine, and methadonea ct through opioid receptors in the spinal cord and brain. [86] These compounds have been used forc enturies to treat pain, cough, and diarrhea. Nowadays, medical use is to treat acute pain. Opioidsa ct by binding to opioid receptors, which are found principally in the central and peripheraln ervouss ystem and the gastrointestinal tract. The concurrent use of opioids with other depressant drugs such as benzodiazepines increases the rates of adversee vents and overdose.
Baheria nd co-workers propose ac olorimetricm ethod for the selectived etection of opioid-based drugs such as morphine,c odeine, oxycodone, noroxycodone, thebaine, tramadol, and methadone in aqueous media on the basis of color changes produced by the aggregation of AuNPs in the presence of these analytes that act as molecular bridges between them (Figure 45) . [87] The sensings ystemsc omprise four citratecoatedA uNPs with different particles izes (diameters of 13, 23, 32, and 43 nm);t hesed ifferent AuNPsp resentd ifferent aggregation behaviors with selected drugs, whichr esultsi nafingerprint pattern in the spectra that can be translated by algorithmic pattern recognition [principal component analysis (PCA) and hierarchical cluster analysis( HCA)] in an array for the classification,i dentification,a nd quantification of these analytes. For each opioid and particles ize, the difference in absorbance (DA)w ith the blank is used as ar esponse, and the effects of critical parameters, such as pH, ionic strength, time of interaction, and analyte concentration, are evaluated. After optimization, discriminationo fs even opioids is possible, with limits of detection of about 5 mmol L À1 (except for noroxycodone), and experiments with severalp otentiali nterfering substances show negligible responses. Finally,c olor-difference maps are obtained before/after exposure for each opioid by using representativeR GB wavelengths (l = 730, 685, and 600 nm), and they show good accuracy andr eproducibility.
Anzenbacher and co-workersp resentanew approachf or sensing heroine, morphine, oxycodone, and their main metabolites on the basis of the interaction of these molecules with the flexible cavity of fluorescent acyclic cucurbituril (aCBs) derivatives ( Figure 46) . [88] ThreeaCBs functionalized with naphthalenes (with different degrees of steric hindrance) in the terminal walls are employed in the sensing protocol. The steric hindrance defines the diametero ft he recognitionc avity in the aCBs. The guestst ested (i.e. heroine, morphine, oxycodone) share ac ommon skeleton with small structurald ifferences. Host-guest recognition resultsi nf luorescence modification of the terminal naphthalene emission, and this induces a" turnon" response for morphine and heroine as ac onsequence of the increased rigidity.H owever,i nt he case of oxycodone, and due to the quencher effect of cyclohexanone on naphthalenes, the fluorescencee mission is diminished. Molecular dynamics calculations confirm that the naphthalene walls and the resultant cavity as well as guest uptake are decisive factors for fluorescence detection. The inducedr esponses of these organic sensors with the studied opiates differ in the amplitude and saturation of the fluorescencec hange, in that the sensors all present different binding isotherms, and this suggestst hat they act as cross-reactive sensors. Furthermore, these organic probess how different behaviors for the studied parentd rugs (i.e. morphine, heroin,a nd oxycodone) and their metabolites (i.e. normorphine, 6-monoacetylmorphine, morphine-3-glucuronide, morphine-6-glucuronide, noroxycodone, and oxymorphone), which makes it possible to determine both in as pecific, qualitative, and quantitative manner.Aq ualitative assayh as been performedi nahigh-throughput fashion by using linear discriminant analysis( LDA) for pattern recognition, and it shows three clusters consistingo ft he parentd rugs and their corresponding metabolites. Ag eneral calibration makes it possible to detect the components of the clusters simultaneously with as ingle fluorescent reading. The limits of detection in aqueous media are 0.07 ppb for morphine and 82.5 and 2.78 ppb for the morphine metabolites morphine-3-glucuronide (M3G) and normorphine( Nmor), respectively.I nh uman urine samples spiked with selected components, the limits of detection are 27.5, 972, and 71.3 ppb form orphine, M3G, and Nmor,respectively.
Only af ew examples of chromo-a nd fluorogenic sensors for the detection of individual opioidsh aveb een described by now,a nd new examples in this area are expected to be reported in the future.
Conclusions
The problematicu se of illicit drugs (both plant-based and synthetic derivatives) associated with their harmfulnesst oh ealth and mortality has urged the scientific community to develop reliable methodologies to detect and quantify these lethal substances.W ehave herein reviewed probesf or the chromo-and fluorogenic detection of illicitd rugs. These probes( which can be simple molecules of more sophisticated systems involving biomolecules or hybrid organic-inorganic materials) provide excellent advantages over traditional analytical techniques, such as their chemical simplicity,e ase of use, rapid response suitable for real-time on-site detection, and easy detection (in certainc ases to the naked eye). However,i ns pite of these remarkable features, the development of chromo-and fluorogenic probes for the selective and sensitive detection of some illicit drugs is still poorly explored. In fact, more than half of the described chromo-and fluorogenic probesh ave been designedf or the recognition/quantification of common plantbased drugs (such as cocaine), yet relatively few works describe the preparation of sensing systems for the detection of new synthetic illicit drugs.I na ddition, most chromo-and fluorogenic detection systems are designed for the detection of illicit drugs in solution, and there are very few examples for their detection in the vapor phase. Moreover,w itht he increasingly ubiquitous internet and other methods of communication, the presence of illicit drugs has expanded in recent years. As these synthetic drugs have not been approved for consumption or medical use, their long-term effects are potentially severef or humans.I nt his scenario, the developmento fn ew, rapid,i nexpensive, and easy-to-use new probesf or these new substances is of importance,a nd new advances in this fielda re expected in the near future.
